We are dedicated to providing access to clinical trials and invest in research across our cancer centres, helping to provide hope and contribute to breakthroughs and advancements in cancer treatments
Express your interest Talk to us about participating in a clinical trial.
Icon Cancer Centre has over 35 years’ experience in cancer research and now operates the largest private cancer clinical trials program in Australia.
We believe patients across our centres deserve the opportunity to access clinical trials and the hope that they offer.
To find out more about the research that Icon is participating in, our team and achievements during 2022, please read the 2022 Icon Research Annual Report.
In 2024 Icon became the first Australian site network to achieve industry endorsed GCSA Global Quality Standard for clinical research sites and the silver standard for IAOCR Workforce Process Quality. This global industry recognition highlights our exceptional global clinical trials and research program and commitment to delivering quality research across our national network.
At Icon, our dedicated research program enables our patients to access new and emerging advances in cancer treatment, giving new hope and opportunities to patients and their families.
We run trials across various tumour types and haematological conditions, including chemotherapy, immunotherapy and radiation therapy trials. Icon also offer trials that aren’t directly connected to a treatment technique, but are focused on wellbeing and improving quality of life for our patients.
By providing access to a wide range of clinical trials across a multitude of cancer types, Icon helps to contribute to breakthroughs and advancements in cancer treatments for the benefit of current and future patients.
If you are interested in taking part in a clinical trial, we are here to help you understand your options.
Icon Cancer Foundation funds Icon doctors and researchers to carry out vital research.
Icon operates Australia’s largest private cancer clinical trials program with a growing reach globally, learn more about our impact to date.
For industry partners interested in working with us on collaborative research or clinical trials please visit Icon Group.
